title: Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.
abstract: Angiotensin converting enzyme (ACE) cleaves amyloid beta peptide. So far this cleavage mechanism has not been studied in detail at atomic level. Keeping this view in mind, we performed molecular dynamics simulation of crystal structure complex of testis truncated version of ACE (tACE) and its inhibitor lisinopril along with Zn(2+) to understand the dynamic behavior of active site residues of tACE. Root mean square deviation results revealed the stability of tACE throughout simulation. The residues Ala 354, Glu 376, Asp 377, Glu 384, His 513, Tyr 520 and Tyr 523 of tACE stabilized lisinopril by hydrogen bonding interactions. Using this information in subsequent part of study, molecular docking of tACE crystal structure with Aβ-peptide has been made to investigate the interactions of Aβ-peptide with enzyme tACE. The residues Asp 7 and Ser 8 of Aβ-peptide were found in close contact with Glu 384 of tACE along with Zn(2+). This study has demonstrated that the residue Glu 384 of tACE might play key role in the degradation of Aβ-peptide by cleaving peptide bond between Asp 7 and Ser 8 residues. Molecular basis generated by this attempt could provide valuable information towards designing of new therapies to control Aβ concentration in Alzheimer's patient.
authors: Department of Microbiology, Shivaji University, Kolhapur, 416 004, Maharashtra (M.S.), India.
authors: Chidambar Balbhim
authors: CB
authors: Jalkute
authors: Sagar Hindurao
authors: SH
authors: Barage
authors: Maruti Jayram
authors: MJ
authors: Dhanavade
authors: Kailas Dasharath
authors: KD
authors: Sonawane
mesh_terms: D000544:Alzheimer Disease / Q000201:enzymology / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000737:chemistry*; D020134:Catalytic Domain; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D017706:Lisinopril / Q000737:chemistry* / Q000378:metabolism; D008297:Male; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D007703:Peptidyl-Dipeptidase A / Q000737:chemistry* / Q000378:metabolism; D013737:Testis / Q000201:enzymology; D015032:Zinc / Q000737:chemistry / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D000806:Angiotensin-Converting Enzyme Inhibitors; D017706:Lisinopril; D007703:Peptidyl-Dipeptidase A; D015032:Zinc
references: J Mol Graph Model. 2003 Nov;22(2):115-26
references: 12932782
references: Acta Biochim Biophys Sin (Shanghai). 2007 Jun;39(6):413-22
references: 17558446
references: Eur J Pharmacol. 1991 Aug 6;200(2-3):289-92
references: 1664329
references: J Comput Chem. 2009 Dec;30(16):2785-91
references: 19399780
references: Am J Cardiol. 2003 Sep 15;92(6):749-51
references: 12972127
references: Neuron. 2004 Sep 30;44(1):181-93
references: 15450169
references: J Biol Chem. 2001 Dec 21;276(51):47863-8
references: 11604391
references: Biophys J. 2007 May 15;92(10):3524-40
references: 17293393
references: J Chem Phys. 2010 May 28;132(20):205101
references: 20515113
references: Ann Intern Med. 2004 Apr 20;140(8):627-38
references: 15096334
references: Nature. 2003 Jan 30;421(6922):551-4
references: 12540854
references: Neurology. 2005 May 10;64(9):1553-62
references: 15883316
references: J Comput Chem. 2005 Dec;26(16):1701-18
references: 16211538
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68
references: 15572779
references: J Mol Graph. 1996 Feb;14(1):33-8, 27-8
references: 8744570
references: J Neurosci. 2007 Aug 8;27(32):8628-35
references: 17687040
references: Eur J Biochem. 1995 Oct 1;233(1):293-8
references: 7588758
references: J Biomed Biotechnol. 2006;2006(3):58406
references: 17047308
references: J Comput Chem. 2004 Oct;25(13):1605-12
references: 15264254
references: Rapid Commun Mass Spectrom. 2008;22(2):231-9
references: 18085519
references: Neurobiol Aging. 2001 Jul-Aug;22(4):541-6
references: 11445253
references: Nat Struct Mol Biol. 2007 Apr;14(4):332-40
references: 17369839
references: Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
references: 15272157
references: J Biol Chem. 2009 Nov 13;284(46):31914-20
references: 19773553
references: Structure. 2007 Sep;15(9):1040-52
references: 17850744
references: Neuron. 2003 May 22;38(4):547-54
references: 12765607
references: Chembiochem. 2008 Jul 2;9(10):1564-7
references: 18506864
references: J Struct Biol. 2000 Jun;130(2-3):88-98
references: 10940217
references: Biochemistry. 1991 Jul 23;30(29):7118-26
references: 1649623
references: Eur J Pharmacol. 2008 Jun 24;588(1):18-25
references: 18495113
references: Eur J Neurosci. 2005 Feb;21(3):733-40
references: 15733091
references: Biophys J. 2001 Oct;81(4):2190-202
references: 11566790
references: Circulation. 2000 Aug 22;102(8):829-32
references: 10952948
references: J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):227-30
references: 9489536
references: Mol Biosyst. 2011 Apr;7(4):1053-5
references: 21350790
references: Alzheimers Res Ther. 2009 Jul 09;1(1):3
references: 19674436
references: J Biol Chem. 1994 Nov 25;269(47):29430-4
references: 7961923
references: J Neurochem. 1982 May;38(5):1490-2
references: 6278093
references: Proc Natl Acad Sci U S A. 1990 Jan;87(1):220-4
references: 2104979
references: Proc Natl Acad Sci U S A. 1989 Oct;86(20):7741-5
references: 2554286
references: J Biol Chem. 1992 Jul 5;267(19):13398-405
references: 1320019
references: Proc Natl Acad Sci U S A. 1988 Dec;85(24):9386-90
references: 2849100